secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACADIA PHARMACEUTICALS INC (ACAD)
CIK:        0001070494
Form:       8-K
Filed at:   2022-06-10T23:59:59+00:00
Accession:  0001193125-22-171917
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Acadia stockholders approve 6M share increase for equity plan, elect directors
------------------------------------------------------------------------------

- Stockholders approved amendment to 2010 Equity Incentive Plan, increasing authorized shares by 6,000,000 (135.2M for, 6.6M against).
- Class III directors Laura A. Brege, Stephen R. Davis, and Elizabeth A. Garofalo elected with 89.4M, 127.1M, and 117.4M votes for, respectively.
- Advisory vote on executive compensation approved (127.2M for, 3.4M against).
- Ratification of Ernst & Young as independent auditor for FY2022 passed (141.5M for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070494/000119312522171917/0001193125-22-171917-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070494/000119312522171917/d364504d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-171917

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer